Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2021 Oct;36(4):416-417.
doi: 10.1007/s12928-020-00741-8.

Correction to: Influence of CYP2C19 genotypes for the effect of 1‑month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12‑month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT‑2

Hirotoshi Watanabe  1 , Takeshi Morimoto  2 , Manabu Ogita  3 , Satoru Suwa  3 , Masahiro Natsuaki  4 , Nobuhiro Suematsu  5 , Yorihiko Koeda  6 , Yoshihiro Morino  6 , Akira Nikaido  7 , Yoshiki Hata  7 , Masayuki Doi  8 , Kiyoshi Hibi  9 , Kazuo Kimura  9 , Shunsuke Yoda  10 , Takeo Kaneko  10 , Koji Nishida  11 , Kazuya Kawai  11 , Koji Yamaguchi  12 , Tetsuzo Wakatsuki  12 , Norimasa Tonoike  13 , Masashi Yamamoto  13 , Shogo Shimizu  14 , Takao Shimohama  15 , Junya Ako  15 , Takeshi Kimura  16 ; STOPDAPT-2 Investigators
Affiliations
Published Erratum

Correction to: Influence of CYP2C19 genotypes for the effect of 1‑month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12‑month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT‑2

Hirotoshi Watanabe et al. Cardiovasc Interv Ther. 2021 Oct.
No abstract available

PubMed Disclaimer

Erratum for

Publication types

LinkOut - more resources